Neodipar - Used for: Treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.
Neodipar is a biguanide antidiabetic. It works by decreasing the amount of sugar that the liver produces and the intestines absorb. It also helps to make your body more sensitive to the insulin that you naturally produce.
Neodipar is an oral antihyperglycemic agent that improves glucose tolerance in patients with NIDDM, lowering both basal and postprandial plasma glucose. Neodipar is not chemically or pharmacologically related to any other class of oral antihyperglycemic agents. Unlike sulfonylureas, Neodipar does not produce hypoglycemia in either patients with NIDDM or healthy subjects and does not cause hyperinsulinemia. Neodipar does not affect insulin secretion.
Neodipar (Ivax) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (Ivax) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (Ivax) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Neodipar (Y.S.) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (Y.S.) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (Y.S.) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Oral Type 2 diabetes mellitus
Adult: Initiate therapy slowly in order to minimise adverse gastric events. Initially 500 mg bid-tid or 850 mg 1-2 times daily, may increase doses in steps of 500 mg at intervals of at least 1 wk. Max: 2.25 g daily.
Child: ≥10 yr: Initiate therapy slowly in order to minimise adverse gastric events. Initially 500 or 850 mg once daily, increase doses either wkly by 500 mg daily or every 2 wk by 850 mg daily to a maintenance dose of 1500 - 2000 mg daily in 2 or 3 divided doses. Max dose 2000 mg daily.
Elderly: Doses may need to be reduced by around a third in elderly patients. Oral Polycystic ovarian syndrome
Adult: Initially 500 mg daily in the morning for 1 wk, then 500 mg bid for 1 wk, then 1.5-1.7 g daily in 2-3 divided doses.
Neodipar (Kingdom) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (Kingdom) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (Kingdom) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Neodipar (S.F.) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (S.F.) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (S.F.) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Neodipar (LIDE) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (LIDE) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (LIDE) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Oral Type 2 DM
Adult: Initiate therapy slowly in order to minimise adverse gastric events. Initially 500 mg bid-tid or 850 mg 1-2 times daily, may increase doses in steps of 500 mg at intervals of at least 1 wk. Max: 2.25 g daily.
Child: ≥10 yr: Initiate therapy slowly in order to minimise adverse gastric events. Initially 500 or 850 mg once daily, increase doses either wkly by 500 mg daily or every 2 wk by 850 mg daily to a maintenance dose of 1500 - 2000 mg daily in 2 or 3 divided doses. Max dose 2000 mg daily.
Elderly: Doses may need to be reduced by around a third in elderly patients. Oral Polycystic ovary syndrome
Adult: Initially 500 mg daily in the morning for 1 wk, then 500 mg bid for 1 wk, then 1.5-1.7 g daily in 2-3 divided doses.
Neodipar (C.H.) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (C.H.) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (C.H.) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Neodipar (T.L.) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (T.L.) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (T.L.) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Indications:
Adult: PO Type 2 DM Initial: 500 mg 2-3 times/day, may increase slowly. Max:2.25 g/day. Polycystic ovary syndrome Initial: 500 mg/day in the morning for 1 wk, then 500 mg twice daily for 1 wk, then 1.5-1.7 g/day in 2-3 divided doses.
Neodipar (Pfoshen) helps treat diabetes by reducing the amount of sugar you absorb from the food you eat. It also reduces the amount of sugar made by your liver. Neodipar (Pfoshen) increases your body's response to insulin and this helps to keep your blood sugar in control. Neodipar (Pfoshen) is meant to be taken as part of a complete diabetes care programme that should include exercise, a healthy diet and regular monitoring of blood sugar levels.
Neodipar is an oral diabetes medicine that helps control blood sugar levels. Metformin is for people with type 2 (non-insulin-dependent) diabetes. Neodipar is sometimes used in combination with insulin or other medications, but it is not for treating type 1 diabetes. |